Pregled bibliografske jedinice broj: 1257160
Off-pump heartmate 3 left ventricular assist device implantation is safe and feasible for high risk patients
Off-pump heartmate 3 left ventricular assist device implantation is safe and feasible for high risk patients // Journal of heart and lung transplantation, 41 (2022), 4
Boston (MA), Sjedinjene Američke Države, 2022. str. s390-s390 doi:10.1016/j.healun.2022.01.1542 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1257160 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Off-pump heartmate 3 left ventricular assist device implantation is safe and feasible for high risk
patients
(Off-pump heartmate 3 left ventricular assist
device implantation is safe and feasible for high
risk patients)
Autori
Wood, K.L. ; Bjelić, Milica ; Paić, Frane ; Hack, M. ; Vidula, H. ; Alexis, J.D. ; Cheyne, C. ; Chase, K. ; Bernstein, W. ; Lindenmuth, D.M. ; Wyrobek, J.A. ; Gosev, I.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Journal of heart and lung transplantation, 41 (2022), 4
/ - , 2022, S390-s390
Skup
ISHLT2022: 42nd Annual Meeting & Scientific Sessions
Mjesto i datum
Boston (MA), Sjedinjene Američke Države, 27.04.2022. - 30.04.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
LVAD ; off-pump ; high risk patients
Sažetak
Purpose While the feasibility of off-pump HeartMate 3 left ventricular assist device (LVAD) placement has already been demonstrated, the safety of this approach has not been reported to date. Methods We retrospectively reviewed all patients who underwent Heartmate 3 LVAD implantation and identified 19 off- pump patients. These were propensity-matched with 19 on-pump cases using the following variables: age, body mass index, INTERMACS profile, and surgical approach. The study's primary objective was the safety of the off-pump technique compared to the standard on-pump approach. Results Preoperative characteristics were similar between the groups (Table 1). Most patients presented with the highest acuity INTERMACS Profile 1 (92.1%). A higher frequency of off-pump patients was supported with extracorporeal membrane oxygenation prior to LVAD implantation (31.6 vs. 89.5%, p=0.001). Intraoperatively, a higher proportion of patients in the off-pump group required packed red blood cells administration (47.4% vs. 84.2%, p=0.038). In the immediate postoperative hours, off-pump patients showed trends toward lower vasoactive-inotropic requirements. Postoperative outcomes, including all of the major complications and short-term survival (Figure 1), were comparable between the groups. Conclusion Results from our retrospective propensity- matched analysis suggest that off-pump LVAD implantation can be offered as a safe alternative for high-risk LVAD candidates.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE